EP2571902

Ný aðferð

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    18.5.2011
  • EP published:
    10.7.2019
  • EP application number:
    11721756.2
  • Max expiry date:
    17.5.2031
  • Expiry date:
    17.5.2026
  • Next due date:
    31.5.2026
  • Title:
    NOVEL PROCESS

Timeline

Today
18.5.2011EP application
10.7.2019EP Publication
30.9.2019Translation submitted
15.10.2019Registration published
17.5.2026Expires

Owner

  • Name:
    GlaxoSmithKline Biologicals S.A.
  • Address:
    Rue de l'Institut, 89, 1330, Rixensart, BE

Inventor

  • Name:
    CHARLES, Philippe
  • Address:
    Rixensart, BE
  • Name:
    GELDHOF, Geoffroy
  • Address:
    Rixensart, BE
  • Name:
    MANCUSO, Vincent
  • Address:
    Rixensart, BE

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    201008401
  • Date:
    20.5.2010
  • Country:
    GB

Classification

  • Categories:
    C08B 37/00, C12P 19/04

Annual fees

Number

Paid

Expires

Payer

Number: 10

Paid: 14.4.2020

Expires: 17.5.2021

Payer: Örn Þór slf.

Number: 11

Paid: 21.4.2021

Expires: 17.5.2022

Payer: Patice ehf.

Number: 12

Paid: 19.4.2022

Expires: 17.5.2023

Payer: Patice ehf.

Number: 13

Paid: 22.4.2023

Expires: 17.5.2024

Payer: Árnason Faktor ehf.

Number: 14

Paid: 19.4.2024

Expires: 17.5.2025

Payer: Árnason Faktor ehf.

Number: 15

Paid: 13.5.2025

Expires: 17.5.2026

Payer: Árnason Faktor ehf.

Upload documents